Advertisement
Screener

MapLight Therapeutics, Inc. (MPLT) Material Contracts

MapLight Therapeutics, Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-08-13: Form 10-Q; Exhibit 10.1; Description Release Agreement by and between the Registrant and Vishwas Setia dated June 18, 2026..
  • 2026-08-13: Form 8-K; Exhibit 10.2; Description Form of Registration Rights Agreement, dated August 13, 2026, by and among MapLight Therapeutics, Inc. and the Purchasers..
  • 2026-08-13: Form 8-K; Exhibit 10.1; Description Form of Securities Purchase Agreement, dated August 13, 2026, by and among MapLight Therapeutics, Inc. and the Purchasers..
  • 2026-05-14: Form 10-Q; Exhibit 10.1; Description Non-Employee Director Compensation Policy.
FiledFormExhibitDescription
2026-08-1310-Q10.1Release Agreement by and between the Registrant and Vishwas Setia dated June 18, 2026.
2026-08-138-K10.2Form of Registration Rights Agreement, dated August 13, 2026, by and among MapLight Therapeutics, Inc. and the Purchasers.
2026-08-138-K10.1Form of Securities Purchase Agreement, dated August 13, 2026, by and among MapLight Therapeutics, Inc. and the Purchasers.
2026-05-1410-Q10.1Non-Employee Director Compensation Policy
2026-03-2610-K10.10NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
2026-03-2610-K10.9First Amendment to Advisor Agreement by and between the Registrant and Robert Malenka, M.D., Ph.D., dated January 1, 2026
2025-12-0410-Q10.7Confirmatory Offer Letter Agreement by and between the Registrant and Erin Pennock Foff, M.D.
2025-12-0410-Q10.6Confirmatory Offer Letter Agreement by and between the Registrant and Vishwas Setia.
2025-12-0410-Q10.5Confirmatory Offer Letter Agreement by and between the Registrant and Christopher A. Kroeger, M.D.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
CAPRICOR THERAPEUTICS, INC. (CAPR)United States$0.499B-10.81
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
PUMA BIOTECHNOLOGY, INC. (PBYI)United States$0.507B15.53